Overweight or Obesity Clinical Trials in Rochester, New York

3 studies are recruiting for overweight or obesity in Rochester, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

    This study will test an experimental drug called olatorepatide ("study drug") to determine how safe and effective this drug is compared to placebo and how easily the body can accept this drug at different doses and dosing schedules without causing side effects, as well as how the drug is processed …

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Rochester Clinical Research, Rochester, New York
    Locations
    18 in total
    Run by
    Regeneron Pharmaceuticals

    See if you can join NCT07685808 on ClinicalTrials.gov

  2. Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

    The YDAN master protocol will support two independent studies, J3R-MC-YOA1 and J3R-MC-YOA2. Each study will investigate how well and safely Eloralintide (LY3841136) works in adults with obesity or overweight who have osteoarthritis (OA) of the knee with pain. Participation in the study will last ab…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Rochester Clinical Research, LLC, Rochester, New York
    Locations
    152 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT07353931 on ClinicalTrials.gov

  3. A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

    The main purpose of this study is to assess the effectiveness of adding tirzepatide to ixekizumab therapy in standard clinical practice in participants with active PsA and obesity or overweight with at least 1 weight-related comorbidity. The study will last up to 12 months.

    Stage
    Phase 4
    Ages
    18 and older
    Site
    University of Rochester Medical Center, Rochester, New York
    Locations
    55 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT06864026 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.